Literature DB >> 950631

Immunopathology of penicillamine-induced glomerular disease.

F E Dische, D R Swinson, E B Hamilton, V Parsons.   

Abstract

Four patients with rheumatoid arthritis developed heavy proteinuria after five to 12 months of treatment with D-penicillamine. Light microscopy of renal biopsy samples showed minimal glomerular capillary wall thickening and mesangial matrix increase, or no departure from normal. Electron microscopy, however, revealed subepithelial electron-dense deposits, fusion of epithelial cell foot processes, and evidence of mesangial cell hyperactivity. Immunofluorescence microscopy demonstrated granular capillary wall deposits of IgG and C3. The findings were similar to those in early membranous glomerulonephritis, differences being observed however in the results of staining for the early-acting complement components C1q and C4. It is tentatively concluded that complement was activated by the classical pathway.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 950631

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Membranous glomerulonephritis in rheumatoid arthritis unassociated with gold or penicillamine treatment.

Authors:  A Higuchi; Y Suzuki; T Okada
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

2.  Penicillamine nephropathy.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-07

Review 3.  Drug-induced nephrotoxicity. Aetiology, clinical features and management.

Authors:  A J Hoitsma; J F Wetzels; R A Koene
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

4.  Natural course of penicillamine nephropathy: a long term study of 33 patients.

Authors:  C L Hall; S Jawad; P R Harrison; J C MacKenzie; P A Bacon; P T Klouda; A G MacIver
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-16

5.  Distribution of [3H]-D-penicillamine in mouse kidney. An autoradiographic study.

Authors:  E de Angelis; M L Lombardi; V Ruocco
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.